Parexel launches new clinical trial management system

By Melissa Fassbender contact

- Last updated on GMT

Parexel launches new clinical trial management system

Related tags: Clinical trial management, Pharmaceutical industry, Clinical trial, Pharmacology

Parexel says pharmaceutical companies could start managing their clinical trials in as little as four weeks with new system.

The US CRO claims the IMPACT Express Clinical Trial Management System (CTMS) offers a new way for small to mid-sized biopharmaceutical companies to manage clinical trials and monitoring – One of the most expensive steps in the drug development process.

“Conducting clinical trials is a complex, challenging series of tasks that involves generating and consolidating data from many sources, coordinating numerous functions, and making timely informed decisions​,” Patrick Nadolny, VP of Product Management, Data and Analytics Services, PAREXEL Informatics told Outsourcing-pharma.com.

Biopharmaceuticals companies can save time and money by applying integrated processes and data driven approaches to trial management and monitoring according to Nadolny, who said the firm's new technology simplifies the process, in addition to improving patient safety oversight and regulatory compliance.

Nadolny said the platform promotes “robust clinical trial management from a single, easy-to-use implement, hosted solution​” adding that capabilitiesinclude oversight, trial tracking, site monitoring, investigator management and selection, as well as payment management.

Industry forecast

When asked what could be expected from the industry in the next five years, Nadolny said advancements in patient centric technology, which will be critical in successfully developing cost effective medicines.

We see many examples of technological devices used in academic and clinical trial settings as an exciting trend towards mHealth​,” he adds. “It is also important to note that clinical trials generate an increasing volume of data that requires new approaches to data integration and analysis​.”

According to Nadolny, drug companies will need to re-engineer their technology platform and corresponding processes to extract the right information to drive real-time decision making.

With the IMPACT Express CTMS, the company is also including a training program and expects pharmaceutical and biopharmaceutical companies to be able to start managing their clinical trials in as little as four weeks.

Related news

Show more

Related products

show more

Laboratory Solutions for COVID-19 Clinical Trials

Laboratory Solutions for COVID-19 Clinical Trials

Q2 Solutions | 10-Jun-2020 | Clinical Study

As a leading laboratory services organization for trials across the globe, we are proud to partner with clients to support COVID-19 clinical trials. Our...

Parents as Gatekeepers for Children with Cancer

Parents as Gatekeepers for Children with Cancer

PRA Health Sciences | 08-Jun-2020 | Technical / White Paper

The RACE for Children Act will require new drugs intended for adult cancer treatment to also be studied in pediatric cancers when the molecular target...

RACE Act Prompts Pediatric Oncology Trials

RACE Act Prompts Pediatric Oncology Trials

PRA Health Sciences | 04-May-2020 | Technical / White Paper

Many providers prescribe drugs off-label to pediatric patients, even though there have been few pediatric trials for many of these drugs. In response,...

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 01-Mar-2020 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

Related suppliers

Follow us

Products

View more

Webinars